NCT00926640
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers treatment 1 completed NCT05349890
Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) treatment 1 enrolling_by_invitation NCT04520711
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) treatment 1 active_not_recruiting NCT01417546
NHS-IL12 for Solid Tumors treatment 1 completed NCT05457595
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies No drug interventions treatment Not Available recruiting NCT04791228
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors treatment 2 recruiting NCT01026415
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) treatment 1 completed NCT01135823
Symptom Assessment With Patient Surveys No drug interventions Not Available Not Available completed NCT00935675
Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment treatment 3 unknown_status NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT05063916
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix treatment 2 active_not_recruiting NCT01148082
School Response to Families Who Have Children With Cancer No drug interventions Not Available Not Available withdrawn NCT05347212
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla treatment 2 recruiting NCT05642195
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer treatment 1 / 2 suspended NCT00879554
A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01016054
A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer treatment 1 terminated NCT00129051
Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases No drug interventions treatment 1 completed NCT00006253
Pain and Fatigue Study No drug interventions supportive_care Not Available completed NCT00688753
RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe treatment 2 completed NCT00152477
A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer treatment 2 completed NCT00243347
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer treatment 1 completed NCT01061645
Study of MOC31-PE in Antigen Positive Carcinomas No drug interventions treatment 1 completed NCT03288298
Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line treatment 0 unknown_status NCT04475705
Propofol vs Sevo for Paediatric Tumor Surgery treatment 4 recruiting NCT02705105
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 completed NCT03562897
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer No drug interventions supportive_care 2 completed NCT03780283
Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC treatment 2 unknown_status NCT00731861
Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors treatment 1 completed NCT05913661
Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma treatment 2 recruiting NCT01149161
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma No drug interventions treatment 2 / 3 unknown_status NCT00781911
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer treatment 2 completed NCT02834611
Ceramide NanoLiposome in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT06013111
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors treatment 1 recruiting NCT05961111
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT01299493
Systems Intervention to Promote Colorectal Cancer (CRC) Screening No drug interventions screening Not Available completed NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT05235607
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors No drug interventions treatment 1 unknown_status NCT04419207
Detecting Lung Cancer Based on Exhaled Breath No drug interventions Not Available Not Available completed NCT02867007
KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT03611556
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. treatment 1 / 2 completed NCT01061515
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer treatment 1 active_not_recruiting NCT00327652
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases treatment 1 completed NCT01215500
Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer No drug interventions treatment 1 completed NCT01942200
A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer No drug interventions Not Available Not Available completed NCT01361100
Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract No drug interventions diagnostic Not Available unknown_status NCT04401059
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study treatment 4 recruiting NCT03765775
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative treatment 2 unknown_status NCT00752570
A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma treatment 2 completed NCT05661370
App Teaches Doctors to Diagnose Skin Cancer No drug interventions other Not Available completed NCT00183742
Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) treatment 1 completed NCT01995942
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial No drug interventions Not Available Not Available unknown_status NCT04600206
Existential Distress in Patients With Advanced Cancer and Their Caregivers No drug interventions Not Available Not Available active_not_recruiting NCT05917106
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) No drug interventions Not Available Not Available recruiting NCT02151149
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly treatment 4 completed NCT00770536
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR treatment 1 completed NCT05065736
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer diagnostic 0 recruiting NCT00396617
Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy No drug interventions treatment 1 unknown_status NCT02567734
Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors No drug interventions treatment Not Available unknown_status NCT03708224
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck treatment 2 recruiting NCT01533324
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT01109524
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer treatment 2 completed NCT01916135
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative No drug interventions diagnostic 1 completed NCT01467635
EBUS-TBNA Versus EBUS-TBNB No drug interventions diagnostic Not Available withdrawn NCT06358222
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan No drug interventions Not Available Not Available recruiting NCT02696525
Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT00804830
Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer treatment 2 terminated NCT00301548
Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer No drug interventions treatment 2 completed NCT00565448
Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents treatment 2 completed NCT05752357
The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer. No drug interventions Not Available Not Available recruiting NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT05283226
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy treatment 2 recruiting NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT00111774
Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma treatment 2 completed NCT00952874
Molecular Biology of Anal Cancer in HIV-Positive Patients No drug interventions Not Available Not Available completed NCT04008082
A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma Not Available Not Available completed NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT05494060
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma treatment 2 recruiting NCT04006691
Efficacy and Safety of UGN-101 in Recurrent Patients No drug interventions treatment 3 withdrawn NCT04033991
Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. Not Available Not Available completed NCT00613691
A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma treatment 1 completed NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT01840280
A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer No drug interventions Not Available Not Available completed NCT03091192
Savolitinib vs. Sunitinib in MET-driven PRCC. treatment 3 active_not_recruiting NCT00989092
Darbepoetin Alfa and Anemia of Cancer supportive_care 2 terminated NCT02507544
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer treatment 1 completed NCT05593744
Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma No drug interventions Not Available Not Available completed NCT06114940
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC treatment 2 recruiting NCT02040467
Registry for Proton Beam Radiation Therapy No drug interventions Not Available Not Available completed NCT02833467
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA No drug interventions Not Available Not Available unknown_status NCT02737501
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants treatment 3 completed NCT03331601
Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients No drug interventions diagnostic 2 recruiting NCT00838201
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer treatment 3 completed NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT04362072
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer treatment 4 active_not_recruiting NCT00894569
Paclitaxel/Carboplatin With or Without Cetuximab in CUP treatment 2 unknown_status NCT00126269
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary treatment 3 unknown_status NCT00446446
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) treatment 2 completed NCT06364046
Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC treatment Not Available not_yet_recruiting NCT04697446
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC No drug interventions Not Available Not Available unknown_status NCT01301612
Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) treatment 2 withdrawn NCT01253681
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer treatment 1 completed NCT00420381
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT01752114
Early Diagnosis of Pulmonary Nodules No drug interventions Not Available Not Available completed NCT06445114
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer treatment 2 not_yet_recruiting NCT00532155
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer treatment 3 completed NCT00599755
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) diagnostic 1 completed NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) treatment 1 / 2 recruiting NCT01668108
A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer No drug interventions Not Available Not Available completed NCT03549338
Sym004 Versus Futuximab or Modotuximab in Patients With mCRC treatment 2 terminated NCT03952403
A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT00099190
ARQ 501 in Combination With Docetaxel in Patients With Cancer treatment 1 completed NCT00719264
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer treatment 2 completed NCT02977364
A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours No drug interventions treatment 1 unknown_status NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) treatment 1 recruiting NCT01345084
Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab treatment 3 withdrawn NCT00034879
Iressa Expanded Access Program (EAP) treatment 3 completed NCT00506051
ZD6474(Vandetanib) + Alimta Combo Study treatment 1 completed NCT04931251
Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings No drug interventions health_services_research Not Available recruiting NCT02303353
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy No drug interventions Not Available Not Available unknown_status NCT02526953
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients treatment 3 unknown_status NCT02592577
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC No drug interventions treatment 1 completed NCT05910177
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin treatment 2 recruiting NCT05848947
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA other 4 completed NCT04124198
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma treatment Not Available recruiting NCT02703298
Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients treatment 1 completed NCT00447005
Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors treatment 1 completed NCT01097083
Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma treatment 2 terminated NCT00466583
Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT03301961
Multiplex Analysis of Circulating Tumor DNA No drug interventions Not Available Not Available unknown_status NCT05023928
Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer No drug interventions treatment 1 unknown_status NCT06317311
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer treatment 2 recruiting NCT06475911
Impact of Peri-Operative Hyponatremia on Postoperative Outcomes in Major HPB Surgeries for Cancers No drug interventions Not Available Not Available recruiting NCT02851693
Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection No drug interventions diagnostic Not Available withdrawn NCT03240393
Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 withdrawn NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT06134193
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer treatment 2 not_yet_recruiting NCT01572493
Continuous Infusion of rhIL-15 for Adults With Advanced Cancer No drug interventions treatment 1 completed NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults treatment 1 active_not_recruiting NCT02629978
Radiofrequency Ablation of Malignant Pulmonary Nodules No drug interventions treatment Not Available unknown_status NCT00822809
CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers treatment 3 completed NCT01223209
A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma Not Available 1 completed NCT00672009
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer treatment 2 terminated NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT01556815
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT01070537
Evaluation of the Bonfils Fiberscope for Predicted Difficult Intubation in Awake Patients With Ear, Nose, and Throat (ENT) Cancer (INVIBO) No drug interventions Not Available 2 completed NCT02539537
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma treatment 3 completed NCT03699332
Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin diagnostic 1 / 2 unknown_status NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer treatment 2 unknown_status NCT00613652
A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients No drug interventions treatment 1 completed NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT05115500
ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) No drug interventions treatment 2 not_yet_recruiting NCT01339975
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT04787042
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 treatment 1 / 2 active_not_recruiting NCT05261399
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment treatment 3 recruiting NCT02907606
Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study No drug interventions Not Available Not Available unknown_status NCT01398306
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. No drug interventions Not Available Not Available completed NCT00518349
Colonoscope Passive Bending Function No drug interventions diagnostic Not Available completed NCT01037049
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks No drug interventions other 2 unknown_status NCT01125449
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease treatment 2 suspended NCT05375136
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients No drug interventions Not Available Not Available completed NCT04641819
Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients No drug interventions treatment 4 active_not_recruiting NCT02292641
Beyond TME Origins No drug interventions treatment Not Available recruiting NCT06112041
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0) treatment 2 not_yet_recruiting NCT02898116
Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer treatment 1 / 2 completed NCT00557596
A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer treatment 1 / 2 terminated NCT05917158
A Study of RC48-ADC Combined With JS001 For Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma treatment 2 recruiting NCT02784158
An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer Not Available Not Available no_longer_available NCT04962958
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery prevention 2 not_yet_recruiting NCT00941863
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006) treatment 1 completed NCT00742222
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer No drug interventions treatment 4 completed NCT00477425
A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab No drug interventions Not Available Not Available withdrawn NCT01553825
Assessment of Patient Experience During Treatment for Cancer No drug interventions Not Available Not Available completed NCT00728130
Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients No drug interventions treatment 1 completed NCT06545630
Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases No drug interventions treatment 1 recruiting NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT05463757
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study Not Available Not Available recruiting NCT06022757
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) treatment 1 / 2 recruiting NCT03634826
Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer). No drug interventions Not Available Not Available unknown_status NCT00027326
Collection of Blood and Urine From Patients Undergoing Radiation Therapy No drug interventions Not Available Not Available enrolling_by_invitation NCT03546166
Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma treatment 2 completed NCT04807166
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer treatment 2 active_not_recruiting NCT02005965
Low Rectal Cancer Study (MERCURY II) No drug interventions Not Available Not Available unknown_status NCT03208374
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling No drug interventions Not Available Not Available active_not_recruiting NCT05860374
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT03515174
Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO No drug interventions supportive_care Not Available active_not_recruiting NCT02433574
Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection No drug interventions treatment Not Available unknown_status NCT03857620
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT05094882
Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010) No drug interventions Not Available Not Available recruiting NCT04124731
Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) treatment 2 unknown_status NCT03549273
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions No drug interventions treatment 2 recruiting NCT02473094
Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer treatment 2 terminated NCT02965391
Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients No drug interventions Not Available Not Available completed NCT01035229
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. treatment 3 completed NCT03778229
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib treatment 2 active_not_recruiting NCT05188729
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma treatment 2 recruiting NCT05744089
Home Management of Simple Hydromorphone PCA Pump Mode No drug interventions treatment Not Available not_yet_recruiting NCT03320044
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing No drug interventions Not Available Not Available completed NCT01752101
Identification of a Plasma Proteomic Signature for Lung Cancer No drug interventions Not Available Not Available completed NCT02840604
What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors No drug interventions Not Available Not Available completed NCT00216372
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis treatment 3 completed NCT05129969
Registry Platform Ovarian and Endometrial Cancer No drug interventions Not Available Not Available recruiting NCT00001569
Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis treatment 1 completed NCT00863746
A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC). treatment 3 completed NCT00847912
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial prevention 4 completed NCT05520281
Short-term Psychodynamic Psychotherapy in Serious Physical Illness No drug interventions treatment Not Available recruiting NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults No drug interventions treatment 1 recruiting NCT00364455
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. treatment 3 completed NCT00688623
RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe treatment 2 completed NCT04419623
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer treatment 1 completed NCT01479023
Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01043523
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions. Not Available Not Available completed NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT00191308
Molecular Profiling in Lung Cancer Patients treatment 2 completed NCT03717038
Sym004 Versus TAS-102 in Patients With mCRC treatment 3 withdrawn NCT00737243
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site treatment 2 completed NCT06128343
Anatomical-Clinical Base of Adenocarcinoma Pancreatic No drug interventions Not Available Not Available recruiting NCT03664843
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT01214343
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC treatment 3 unknown_status NCT00097903
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer treatment 1 completed NCT05225090
Smartphone App for Cancer Medication Adherence No drug interventions supportive_care Not Available recruiting NCT04429490
Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma No drug interventions basic_science Not Available unknown_status NCT00816764
A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer No drug interventions treatment 1 completed NCT01614002
A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer No drug interventions Not Available Not Available completed NCT00879684
Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00799084
Automated Telephone Monitoring for Symptom Management No drug interventions supportive_care 2 completed NCT05559879
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma treatment 1 / 2 recruiting